Litcius/Paper detail

Ribosomal stalk-captured CARF-RelE ribonuclease inhibits translation following CRISPR signaling

Irmantas Mogila, Giedrė Tamulaitienė, Konstanty Keda, Albertas Timinskas, Audronė Rukšėnaitė, Giedrius Sasnauskas, Česlovas Venclovas, Virginijus Šikšnys, Gintautas Tamulaitis

2023Science27 citationsDOI

Abstract

Prokaryotic type III CRISPR-Cas antiviral systems employ cyclic oligoadenylate (cA n ) signaling to activate a diverse range of auxiliary proteins that reinforce the CRISPR-Cas defense. Here we characterize a class of cA n -dependent effector proteins named CRISPR-Cas-associated messenger RNA (mRNA) interferase 1 (Cami1) consisting of a CRISPR-associated Rossmann fold sensor domain fused to winged helix-turn-helix and a RelE-family mRNA interferase domain. Upon activation by cyclic tetra-adenylate (cA 4 ), Cami1 cleaves mRNA exposed at the ribosomal A-site thereby depleting mRNA and leading to cell growth arrest. The structures of apo-Cami1 and the ribosome-bound Cami1-cA 4 complex delineate the conformational changes that lead to Cami1 activation and the mechanism of Cami1 binding to a bacterial ribosome, revealing unexpected parallels with eukaryotic ribosome-inactivating proteins.

Topics & Concepts

RibonucleaseCRISPRTranslation (biology)Ribosomal RNAEffectorRibosomeCell biologyMessenger RNABiologyRibosomal proteinRNAChemistryBiochemistryGeneCRISPR and Genetic EngineeringRNA and protein synthesis mechanismsViral Infections and Immunology Research
Ribosomal stalk-captured CARF-RelE ribonuclease inhibits translation following CRISPR signaling | Litcius